|
Canertinib
|
卡奈替尼
|
267243-28-7
|
|
AEE788 (NVP-AEE788)
|
6-[4-[(4-乙基-1-哌嗪)甲基]苯基]-N-[(1R)-1-苯基乙基]-7H-吡咯并[2,3-D]嘧啶-4-胺
|
497839-62-0
|
|
Navtemadlin
|
2-((3R,5R,6S)-5-(3-氯苯基)-6-(4-氯苯基)-1-((S)-1-(异丙基磺酰基)-3-甲基丁烷-2-基)-3-甲基-2-氧代哌啶-3-基)乙酸
|
1352066-68-2
|
|
Pyrotinib dimaleate
|
马来酸吡咯替尼
|
1397922-61-0
|
|
DI-591
|
DI-591
|
2245887-38-9
|
|
RTC-5
|
RTC-5
|
1423077-49-9
|
|
EGFR-IN-7
|
5-溴-N4-[5-(二甲基膦基)-6-喹喔啉基]-N2-[2-甲氧基-5-甲基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-2,4-嘧啶二胺
|
2267329-76-8
|
|
WS-383
|
WS-383
|
2247544-02-9
|
|
Thalidomide-PEG2-C2-NH2 TFA
|
Thalidomide-NH-PEG2-C2-NH2 (TFA)
|
2097509-36-7
|
|
BI-4020
|
RESATORVID
|
2664214-60-0
|
|
Gefitinib hydrochloride
|
4-(3-氯-4-氟苯基氨基)-7-甲氧基-6-[3-(4-吗啉基)丙氧基]喹唑啉盐酸盐
|
184475-55-6
|
|
AP26113
|
AP26113
|
1197958-12-5
|
|
TZ9
|
1002789-86-7
|
1002789-86-7
|
|
Mavelertinib
|
PF-06747775
|
1776112-90-3
|
|
(S,R,S)-AHPC-PEG4-NH2 hydrochloride
|
2064292-52-8
|
2064292-52-8
|
|
Pomalidomide-PEG1-C2-COOH
|
POMALIDOMIDE-PEG 1-CO 2 H
|
2139348-60-8
|
|
(S,R,S)-AHPC-PEG3-NH2
|
E3 ligase Ligand-Linker Conjugates 5 Free Base
|
2010159-56-3
|
|
Almonertinib
|
阿美替尼
|
1899921-05-1
|
|
C25-140
|
C25-140
|
1358099-18-9
|
|
Pomalidomide-amino-PEG3-NH2 hydrochloride
|
POMALIDOMIDE-PEG3-NH2盐酸盐
|
2380273-75-4
|
|
Subasumstat
|
TAK-981
|
1858276-04-6
|
|
Pomalidomide-PEG3-C2-NH2 TFA
|
沙利度胺-NH-PEG3-NH2 TFA
|
2414913-97-4
|
|
NSC689857
|
化合物 T25889
|
241127-79-7
|
|
Trastuzumab deruxtecan
|
Trastuzumab Deruxtecan
|
1826843-81-5
|
|
Pomalidomide-PEG4-C2-NH2 hydrochloride
|
泊马度胺4'-PEG4-胺
|
2357105-92-9
|
|
Tyrphostin AG30
|
酪氨酸磷酸化抑制剂 AG 30
|
122520-79-0
|
|
WZ8040
|
WZ8040
|
1214265-57-2
|
|
Lapatinib-d4
|
Lapatinib-d4
|
1184263-99-7
|
|
Icotinib Hydrochloride
|
凯美纳
|
1204313-51-8
|
|
Theliatinib
|
席栗替尼
|
1353644-70-8
|
|
Thalidomide-O-amido-PEG3-C2-NH2 TFA
|
1957236-21-3
|
1957236-21-3
|
|
AG-18
|
酪氨酸磷酸化抑制剂23
|
118409-57-7
|
|
VH032-PEG5-C6-Cl
|
1799506-06-1
|
1799506-06-1
|
|
Alflutinib mesylate
|
AST2818甲磺酸盐
|
2130958-55-1
|
|
JND3229
|
JND3229
|
2260886-64-2
|
|
MRT00033659
|
MRT00033659
|
1401731-54-1
|
|
WSB1 Degrader 1
|
化合物WSB1 DEGRADER 1
|
2306039-66-5
|
|
Pomalidomide 4'-PEG2-azide
|
4-((2-(2-(2-azidoethoxy)ethoxy)ethyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
|
2271036-45-2
|
|
Lapatinib ditosylate monohydrate
|
二甲苯磺酸拉帕替尼
|
388082-78-8
|
|
HB007
|
HB007
|
2387821-46-5
|
|
Idasanutlin
|
RG 7388
|
1229705-06-9
|
|
Nazartinib
|
EGF816
|
1508250-71-2
|
|
Gefitinib-based PROTAC 3
|
Gefitinib-based PROTAC 3
|
2230821-27-7
|
|
ML401
|
ML401
|
1597489-14-9
|
|
(S,R,S)-AHPC-phenol-C4-NH2 dihydrochloride
|
(S,R,S)-AHPC-PHENOL-C4-NH2 (DIHYDROCHLORIDE)
|
2376990-26-8
|
|
(S,R,S)-AHPC-PEG5-COOH
|
E3 Ligase Ligand-Linker Conjugates 58
|
2172820-14-1
|
|
Rezivertinib
|
REZIVERTINIB
|
1835667-12-3
|
|
BMS-690514
|
(3R,4R)-4-氨基-1-[[4-[(3-甲氧基苯基)氨基]吡咯并[2,1-F][1,2,4]三嗪-5-基]甲基]哌啶-3-醇
|
859853-30-8
|
|
CC0651
|
4,5-二脱氧-5-(3',5'-二氯[1,1'-联苯]-4-基)-4-[(2-甲氧基乙酰基)氨基]-L-阿拉伯糖酸
|
1319207-44-7
|
|
SAR405838
|
SAR 405838
|
1303607-60-4
|
|
BC-1382
|
化合物BC-1382
|
1013753-99-5
|
|
MX69
|
MX69
|
1005264-47-0
|
|
EAI001
|
2-(1-氧代异吲哚啉-2-基)-2-苯基-N-(噻唑-2-基)乙酰胺
|
892772-75-7
|
|
Pomalidomide-PEG2-COOH
|
POMALIDOMIDE-PEG2-CO 2 H
|
2140807-17-4
|
|
AZ7550 Mesylate
|
AZ7550 Mesylate
|
2319837-99-3
|
|
MI-1061
|
MI-1061
|
1410737-34-6
|
|
SENP1-IN-1
|
|
2416910-69-3
|
|
MD-222
|
MD-222
|
2136246-72-3
|
|
Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 TFA
|
THALIDOMIDE-O-AMIDO-PEG1-(C1-?PEG)2-C2-NH2
|
2435572-49-7
|
|
CP-724714
|
2-甲氧基-N-[3-[4-[[3-甲基-4-[(6-甲基-3-吡啶基)氧基]苯基]氨基]-6-喹唑啉基]-2-丙烯-1-基]乙酰胺
|
537705-08-1
|
|
Pomalidomide-PEG4-C-COOH
|
E3 Ligase Ligand-Linker Conjugates 1
|
2097938-44-6
|
|
Thalidomide-O-amido-C3-COOH
|
E3 ligase Ligand-Linker Conjugates 15
|
2308035-51-8
|
|
Thalidomide-O-amido-C8-NH2 TFA
|
1950635-16-1
|
1950635-16-1
|
|
TAS0728
|
TAS0728
|
2088323-16-2
|
|
Cbl-b-IN-1
|
CBL-B-IN-1
|
2368841-84-1
|
|
Thalidomide-O-C6-COOH
|
Heptanoic acid, 7-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]-
|
2169266-69-5
|
|
Thalidomide-Piperazine-PEG1-COOH
|
|
2731007-11-5
|
|
Teslexivir hydrochloride
|
BTA074 HYDROCHLORIDE ; AP 611074 HYDROCHLORIDE|||BTA074 HYDROCHLORIDE|||AP 611074 HYDROCHLORIDE
|
1075281-70-7
|
|
ARRY-380 analog
|
ARRY-380
|
937265-83-3
|
|
GSK682753A
|
1334294-76-6
|
1334294-76-6
|
|
(S,R,S)-AHPC-(C3-PEG)2-C6-Cl
|
1835705-61-7
|
1835705-61-7
|
|
Thalidomide-O-amido-C4-NH2 TFA
|
1799711-25-3
|
1799711-25-3
|
|
Zipalertinib
|
1661854-97-2
|
1661854-97-2
|
|
Thalidomide-piperazine-Boc
|
1-Piperazinecarboxylic acid, 4-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-5-yl]-, 1,1-dimethylethyl ester
|
2222114-64-7
|
|
Hydrocotarnine
|
hydrocotarnine
|
550-10-7
|
|
Avadomide
|
3-(5-氨基-2-甲基-4-氧代喹唑啉-3(4H)-基)哌啶-2,6-二酮
|
1015474-32-4
|
|
N106
|
N-(4-甲氧基苯并[D]噻唑-2-基)-5-(4-甲氧基苯基)-1,3,4-噁二唑-2-胺
|
862974-25-2
|
|
(E/Z)-AG490
|
酪氨酸磷酸化抑制剂AG490
|
134036-52-5
|
|
Thalidomide-NH-C6-NH2 TFA
|
Thalidomide-NH-C6-NH2 TFA
|
2093386-51-5
|
|
PKI-166
|
PKI 166
|
187724-61-4
|
|
DI-1859
|
化合物 DI-1859
|
2247061-09-0
|
|
EGFR-IN-11
|
EGFR-IN-11
|
2463200-44-2
|
|
Pomalidomide-amino-PEG5-NH2 hydrochloride
|
泊马度胺-五聚乙二醇-氨基盐酸盐
|
2421217-05-0
|
|
YH239-EE
|
YH239-EE,YH239乙酯
|
1364488-67-4
|
|
NIBR189
|
NIBR189
|
1599432-08-2
|
|
RO8994
|
RO 8994
|
1309684-94-3
|
|
EAI045
|
EAI-045
|
1942114-09-1
|
|
PD168393
|
PD168393
|
194423-15-9
|
|
Lazertinib
|
YH-25448
|
1903008-80-9
|
|
BI8622
|
化合物 T14568
|
1875036-74-0
|
|
Simotinib
|
Simotinib
|
944258-89-3
|
|
Thalidomide-O-amido-C6-NH2 TFA
|
1950635-14-9
|
1950635-14-9
|
|
Thalidomide-NH-PEG3-propionic acid
|
Pomalidomide-PEG3-CO2H
|
2138440-82-9
|
|
Almonertinib mesylate
|
阿美替尼甲磺酸盐
|
2134096-06-1
|
|
Thalidomide-O-amido-C3-PEG3-C1-NH2
|
沙利度胺-O-酰胺-C3-三聚乙二醇-C1-氨基
|
1799711-29-7
|
|
HLM006474
|
CS-1224
|
353519-63-8
|
|
(S,R,S)-AHPC-PEG2-N3
|
2010159-45-0
|
2010159-45-0
|
|
Thalidomide 4'-ether-alkylC2-amine hydrochloride
|
Thalidomide-linker 6
|
2341840-99-9
|
|
Pomalidomide-PEG1-C2-N3
|
E3 ligase Ligand-Linker Conjugates 50
|
2271036-44-1
|
|
Thalidomide-NH-C4-NH-Boc
|
泊马度胺-NH-C4-氨基叔丁酯
|
2093388-52-2
|